Literature DB >> 17514765

Microstructure of trabecular bone in a mouse model for Down syndrome.

Trish Parsons1, Timothy M Ryan, Roger H Reeves, Joan T Richtsmeier.   

Abstract

Down syndrome (DS) is caused by trisomy of human chromosome 21 (Hsa21) and results in a suite of dysmorphic phenotypes, including effects on the postcranial skeleton and the skull. We have previously demonstrated parallels in the patterns of craniofacial dysmorphology in DS and in the Ts65Dn mouse model for DS. The specific mechanisms underlying the production of these changes in craniofacial shape remain unknown. High-resolution computed tomography scan data were collected for the presphenoid bone of euploid and aneuploid mice. Three-dimensional morphometric parameters of trabecular bone were quantified and compared between euploid and aneuploid mice using nonparametric statistical tests. Aneuploid presphenoid bones were smaller than those of their euploid littermates and had lower bone volume fraction and fewer, more rod-like trabeculae. The differences in cancellous bone structure suggest that bone development, perhaps including bone modeling and remodeling, is affected by aneuploidy. These differences may contribute to the observed dysmorphology of skull and postcranial skeletal phenotypes in DS.

Entities:  

Mesh:

Year:  2007        PMID: 17514765     DOI: 10.1002/ar.20494

Source DB:  PubMed          Journal:  Anat Rec (Hoboken)        ISSN: 1932-8486            Impact factor:   2.064


  10 in total

1.  Disruption of bone development and homeostasis by trisomy in Ts65Dn Down syndrome mice.

Authors:  Joshua D Blazek; Anna Gaddy; Rachel Meyer; Randall J Roper; Jiliang Li
Journal:  Bone       Date:  2010-09-24       Impact factor: 4.398

Review 2.  Prospects for improving brain function in individuals with Down syndrome.

Authors:  Alberto C S Costa; Jonah J Scott-McKean
Journal:  CNS Drugs       Date:  2013-09       Impact factor: 5.749

3.  The Influence of trisomy 21 on facial form and variability.

Authors:  John M Starbuck; Theodore M Cole; Roger H Reeves; Joan T Richtsmeier
Journal:  Am J Med Genet A       Date:  2017-09-21       Impact factor: 2.802

4.  Overlapping trisomies for human chromosome 21 orthologs produce similar effects on skull and brain morphology of Dp(16)1Yey and Ts65Dn mice.

Authors:  John M Starbuck; Tara Dutka; Tabetha S Ratliff; Roger H Reeves; Joan T Richtsmeier
Journal:  Am J Med Genet A       Date:  2014-05-01       Impact factor: 2.802

5.  Trisomy 21 and facial developmental instability.

Authors:  John M Starbuck; Theodore M Cole; Roger H Reeves; Joan T Richtsmeier
Journal:  Am J Phys Anthropol       Date:  2013-03-15       Impact factor: 2.868

6.  Brain phenotypes in two FGFR2 mouse models for Apert syndrome.

Authors:  Kristina Aldridge; Cheryl A Hill; Jordan R Austin; Christopher Percival; Neus Martinez-Abadias; Thomas Neuberger; Yingli Wang; Ethylin Wang Jabs; Joan T Richtsmeier
Journal:  Dev Dyn       Date:  2010-03       Impact factor: 3.780

7.  A quantitative method for the evaluation of three-dimensional structure of temporal bone pneumatization.

Authors:  Cheryl A Hill; Joan T Richtsmeier
Journal:  J Hum Evol       Date:  2008-08-19       Impact factor: 3.895

8.  Interaction of sexual dimorphism and gene dosage imbalance in skeletal deficits associated with Down syndrome.

Authors:  Jared R Thomas; Jonathan LaCombe; Rachel Long; Eva Lana-Elola; Sheona Watson-Scales; Joseph M Wallace; Elizabeth M C Fisher; Victor L J Tybulewicz; Randall J Roper
Journal:  Bone       Date:  2020-04-17       Impact factor: 4.398

9.  Low bone turnover and low BMD in Down syndrome: effect of intermittent PTH treatment.

Authors:  Tristan W Fowler; Kent D McKelvey; Nisreen S Akel; Jaclyn Vander Schilden; Anthony W Bacon; John W Bracey; Timothy Sowder; Robert A Skinner; Frances L Swain; William R Hogue; Donna B Leblanc; Dana Gaddy; Galen R Wenger; Larry J Suva
Journal:  PLoS One       Date:  2012-08-14       Impact factor: 3.240

Review 10.  Down syndrome--recent progress and future prospects.

Authors:  Frances K Wiseman; Kate A Alford; Victor L J Tybulewicz; Elizabeth M C Fisher
Journal:  Hum Mol Genet       Date:  2009-04-15       Impact factor: 6.150

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.